Zealand Pharma increases its share capital as a consequence of exercise of employee warrants
(WorldNews Denmark)

Company announcement - No. 22 / 2018 Zealand Pharma increases its share capital as a consequence of exercise of employee warrants Copenhagen, September 14, 2018 - Zealand Pharma A/S (`Zealand`) (NASDAQ: ZEAL), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, has increased its share capital by a nominal amount of DKK 7,500 divided into 7,500 new shares with a nominal value of DKK 1 each. The increase is a consequence of the...